• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡 T 细胞反应的独特进化与未接种疫苗的 SARS-CoV-2 肺炎患者的临床结局相关。

Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Simpson Querrey Lung Institute for Translational Science, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Nat Immunol. 2024 Sep;25(9):1607-1622. doi: 10.1038/s41590-024-01914-w. Epub 2024 Aug 13.

DOI:10.1038/s41590-024-01914-w
PMID:39138384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11490290/
Abstract

The evolution of T cell molecular signatures in the distal lung of patients with severe pneumonia is understudied. Here, we analyzed T cell subsets in longitudinal bronchoalveolar lavage fluid samples from 273 patients with severe pneumonia, including unvaccinated patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with respiratory failure not linked to pneumonia. In patients with SARS-CoV-2 pneumonia, activation of interferon signaling pathways, low activation of the NF-κB pathway and preferential targeting of spike and nucleocapsid proteins early after intubation were associated with favorable outcomes, whereas loss of interferon signaling, activation of NF-κB-driven programs and specificity for the ORF1ab complex late in disease were associated with mortality. These results suggest that in patients with severe SARS-CoV-2 pneumonia, alveolar T cell interferon responses targeting structural SARS-CoV-2 proteins characterize individuals who recover, whereas responses against nonstructural proteins and activation of NF-κB are associated with poor outcomes.

摘要

T 细胞分子特征在严重肺炎患者远端肺部的演变尚未得到充分研究。在这里,我们分析了 273 例严重肺炎患者的纵向支气管肺泡灌洗液样本中的 T 细胞亚群,其中包括未接种疫苗的感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)或与肺炎无关的呼吸衰竭患者。在 SARS-CoV-2 肺炎患者中,干扰素信号通路的激活、NF-κB 通路的低激活以及在插管后早期对刺突蛋白和核衣壳蛋白的优先靶向与良好结局相关,而干扰素信号的丧失、NF-κB 驱动的程序的激活以及 ORF1ab 复合物的特异性与疾病晚期的死亡率相关。这些结果表明,在严重 SARS-CoV-2 肺炎患者中,针对结构 SARS-CoV-2 蛋白的肺泡 T 细胞干扰素反应特征是恢复的个体,而针对非结构蛋白的反应和 NF-κB 的激活与不良结局相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/219ac5595ec1/nihms-2023834-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/2de98b65261a/nihms-2023834-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/f596227ecc29/nihms-2023834-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/54d058842abf/nihms-2023834-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/d7cc407b2fc7/nihms-2023834-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/9cd1c1a04cfc/nihms-2023834-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/386829b165e8/nihms-2023834-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/8d1f8ca6e798/nihms-2023834-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/49cfff021def/nihms-2023834-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/f9c45f8ab2f1/nihms-2023834-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/56e4e34636c6/nihms-2023834-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/56d2d79e69db/nihms-2023834-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/86e3ecaec8f7/nihms-2023834-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/94e946d92cb1/nihms-2023834-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/24d7b532a715/nihms-2023834-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/9bff3e980993/nihms-2023834-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/05aff5a67096/nihms-2023834-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/219ac5595ec1/nihms-2023834-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/2de98b65261a/nihms-2023834-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/f596227ecc29/nihms-2023834-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/54d058842abf/nihms-2023834-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/d7cc407b2fc7/nihms-2023834-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/9cd1c1a04cfc/nihms-2023834-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/386829b165e8/nihms-2023834-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/8d1f8ca6e798/nihms-2023834-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/49cfff021def/nihms-2023834-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/f9c45f8ab2f1/nihms-2023834-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/56e4e34636c6/nihms-2023834-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/56d2d79e69db/nihms-2023834-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/86e3ecaec8f7/nihms-2023834-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/94e946d92cb1/nihms-2023834-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/24d7b532a715/nihms-2023834-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/9bff3e980993/nihms-2023834-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/05aff5a67096/nihms-2023834-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e87a/11490290/219ac5595ec1/nihms-2023834-f0008.jpg

相似文献

1
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.肺泡 T 细胞反应的独特进化与未接种疫苗的 SARS-CoV-2 肺炎患者的临床结局相关。
Nat Immunol. 2024 Sep;25(9):1607-1622. doi: 10.1038/s41590-024-01914-w. Epub 2024 Aug 13.
2
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection.野生型感染250天后康复的未接种疫苗个体中可检测到的SARS-CoV-2特异性免疫反应。
PLoS One. 2025 Jun 11;20(6):e0325923. doi: 10.1371/journal.pone.0325923. eCollection 2025.
3
A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.肺泡T细胞反应的独特演变与未接种疫苗的新冠病毒肺炎患者的临床结果相关。
bioRxiv. 2023 Dec 14:2023.12.13.571479. doi: 10.1101/2023.12.13.571479.
4
Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.SARS-CoV-2 感染个体在针对刺突糖蛋白的抗体反应的域特异性和相对效力方面存在有限的变异性。
Microbiol Spectr. 2022 Feb 23;10(1):e0267621. doi: 10.1128/spectrum.02676-21. Epub 2022 Jan 26.
5
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer.头颈癌患者对新型冠状病毒的体液免疫和细胞免疫反应
Viruses. 2025 Jun 13;17(6):848. doi: 10.3390/v17060848.
6
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants.在雅芳亲子纵向研究(ALSPAC)参与者中,B细胞和T细胞混合免疫与严重急性呼吸综合征冠状病毒2疫苗接种后预防突破性感染相关。
J Infect Dis. 2025 Aug 14;232(2):e327-e340. doi: 10.1093/infdis/jiaf246.
7
CCR2 Signaling Restricts SARS-CoV-2 Infection.CCR2 信号限制 SARS-CoV-2 感染。
mBio. 2021 Dec 21;12(6):e0274921. doi: 10.1128/mBio.02749-21. Epub 2021 Nov 9.
8
SARS-CoV-2 Nsp14 binds Tollip and activates pro-inflammatory pathways while downregulating interferon-α and interferon-γ receptors.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白14(Nsp14)与Toll相互作用蛋白(Tollip)结合并激活促炎途径,同时下调I型干扰素(IFN-α)和II型干扰素(IFN-γ)受体。
mBio. 2025 Jun 25:e0107125. doi: 10.1128/mbio.01071-25.
9
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.常见的 HLA 等位基因与无症状 SARS-CoV-2 感染相关。
Nature. 2023 Aug;620(7972):128-136. doi: 10.1038/s41586-023-06331-x. Epub 2023 Jul 19.
10
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.

引用本文的文献

1
Novel enzyme-based reduced representation method for DNA methylation profiling with low inputs.基于新型酶的低输入量DNA甲基化谱分析的简化表征方法。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf558.
2
Regulatory T Cells Require TBET to Regulate Activated CD8+ T Cells During Recovery from Influenza.在流感恢复过程中,调节性T细胞需要T-bet来调节活化的CD8 + T细胞。
Am J Respir Cell Mol Biol. 2025 Apr;72(4):453-456. doi: 10.1165/rcmb.2024-0254LE.
3
Maintenance DNA methylation is required for induced regulatory T cell reparative function following viral pneumonia.

本文引用的文献

1
Principles and therapeutic applications of adaptive immunity.适应性免疫的原理和治疗应用。
Cell. 2024 Apr 25;187(9):2052-2078. doi: 10.1016/j.cell.2024.03.037.
2
Prolonged exposure to lung-derived cytokines is associated with activation of microglia in patients with COVID-19.长期暴露于源自肺部的细胞因子与新冠肺炎患者小胶质细胞的激活有关。
JCI Insight. 2024 Mar 19;9(8):e178859. doi: 10.1172/jci.insight.178859.
3
An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline.
维持DNA甲基化是病毒性肺炎后诱导调节性T细胞修复功能所必需的。
bioRxiv. 2025 Mar 1:2025.02.25.640199. doi: 10.1101/2025.02.25.640199.
4
Distinct CD8 T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2 Patients.未接种疫苗的HLA - A2患者中与新冠严重程度相关的不同CD8 T细胞类型
bioRxiv. 2025 Jan 14:2025.01.12.632164. doi: 10.1101/2025.01.12.632164.
5
Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19.衰老和炎症会限制重症 COVID-19 患者中 SARS-CoV-2 特异性 CD8+ T 细胞反应的诱导。
JCI Insight. 2025 Jan 23;10(4):e180867. doi: 10.1172/jci.insight.180867.
6
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.组织中对新冠疫苗免疫记忆的维持与功能调节。
Immunity. 2024 Dec 10;57(12):2895-2913.e8. doi: 10.1016/j.immuni.2024.10.003. Epub 2024 Nov 6.
7
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和疫苗接种的T细胞免疫反应
Vaccines (Basel). 2024 Sep 30;12(10):1126. doi: 10.3390/vaccines12101126.
8
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates.一种用于在非人灵长类动物中联合预防新冠病毒和流感的二价疫苗的安全性和免疫原性研究。
Vaccines (Basel). 2024 Sep 26;12(10):1099. doi: 10.3390/vaccines12101099.
9
IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN.IFN-λ 相对于 I 型 IFN ,特异性地促进 CD8 T 细胞对 SARS-CoV-2 的免疫应答。
JCI Insight. 2024 May 21;9(13):e171830. doi: 10.1172/jci.insight.171830.
10
FOXP3+ Regulatory T Cells Require TBET to Regulate Activated CD8+ T Cells During Recovery from Influenza Infection.在流感感染恢复过程中,FOXP3 + 调节性T细胞需要T-bet来调节活化的CD8 + T细胞。
bioRxiv. 2024 Jun 2:2024.05.30.596295. doi: 10.1101/2024.05.30.596295.
成人急性呼吸窘迫综合征管理的最新进展:美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2024 Jan 1;209(1):24-36. doi: 10.1164/rccm.202311-2011ST.
4
An Adjudication Protocol for Severe Pneumonia.重症肺炎的判定方案
Open Forum Infect Dis. 2023 Jul 1;10(7):ofad336. doi: 10.1093/ofid/ofad336. eCollection 2023 Jul.
5
Differential roles of regulatory T cells in acute respiratory infections.调节性 T 细胞在急性呼吸道感染中的差异作用。
J Clin Invest. 2023 Jul 17;133(14):e170505. doi: 10.1172/JCI170505.
6
rrvgo: a Bioconductor package for interpreting lists of Gene Ontology terms.RRVGO:一个用于解释基因本体术语列表的Bioconductor软件包。
MicroPubl Biol. 2023 Apr 18;2023. doi: 10.17912/micropub.biology.000811. eCollection 2023.
7
Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19.机器学习将未解决的继发性肺炎与包括 COVID-19 在内的重症肺炎患者的死亡率联系起来。
J Clin Invest. 2023 Jun 15;133(12):e170682. doi: 10.1172/JCI170682.
8
Resolving SARS-CoV-2 CD4 T cell specificity via reverse epitope discovery.通过反向表位发现解析 SARS-CoV-2 CD4 T 细胞特异性。
Cell Rep Med. 2022 Aug 16;3(8):100697. doi: 10.1016/j.xcrm.2022.100697. Epub 2022 Jul 1.
9
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.预先存在的聚合酶特异性 T 细胞在 SARS-CoV-2 无血清学阴性中扩增。
Nature. 2022 Jan;601(7891):110-117. doi: 10.1038/s41586-021-04186-8. Epub 2021 Nov 10.
10
Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia.新型冠状病毒肺炎机械通气患者的细菌重叠感染性肺炎
Am J Respir Crit Care Med. 2021 Oct 15;204(8):921-932. doi: 10.1164/rccm.202106-1354OC.